Sun Park

Executive Vice President, Strategy and Development

Sun Park is Executive Vice President, Strategy and Development. Prior to joining AmerisourceBergen in 2012, he served in various leadership roles across corporate development, corporate strategy and R&D portfolio management at MedImmune, the global biologics division of AstraZeneca. Before joining MedImmune, he held positions at Charterhouse Group International and Merrill Lynch & Company.

Mr. Park graduated from Yale University and attained his Master’s degree in Biotechnology from The John Hopkins University.

    Corporate Overview

    AmerisourceBergen is one of the largest global pharmaceutical sourcing and distribution services companies, helping both healthcare providers and pharmaceutical and biotech manufacturers improve patient access to products and enhance patient care. With services ranging from drug distribution and niche premium logistics to reimbursement and pharmaceutical consulting services, AmerisourceBergen delivers innovative programs and solutions across the pharmaceutical supply channel..

    Learn More